Gene · 2057
Papers3,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation of the EPO-EPOR axis enhances dopamine agonist sensitivity through mitochondrial STAT5A-mediated suppression of mtDNA transcription in prolactinomas. | Pharmacol Res | 2026 | 42822553 | PubTator, text mining | PubMed |
| Unexpected functional role of the transactivation domain for nuclear import of STAT5. | Commun Biol | 2026 | 42800796 | PubTator, text mining | PubMed |
| Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities. | Cancers (Basel) | 2026 | 42794978 | PubTator, text mining | PubMed |
| Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease. | Int J Mol Sci | 2026 | 42794474 | PubTator, text mining | PubMed |
| Role of hypoxia-inducible factor - 1 alpha on the progression of cervical intraepithelial neoplasia and cervical cancer: a narrative review. | Front Oncol | 2026 | 42787653 | PubTator, text mining | PubMed |
| In vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cells. | bioRxiv | 2026 | 42779985 | PubTator, text mining | PubMed |
| Erythropoietin impacts immune adaptation through myeloid-cell programming. | Trends Immunol | 2026 | 42749579 | PubTator, text mining | PubMed |
| Author Correction: Erythropoietin receptor on cDC1s dictates immune tolerance. | Nature | 2026 | 42744852 | PubTator, text mining | PubMed |
| Flow Cytometric Detection of Intracellular Proteins in K562 Human Erythroleukemia Cells Using Unconjugated Primary Antibodies. | J Vis Exp | 2026 | 42714009 | PubTator, text mining | PubMed |
| Integrated microbial and transcriptomic profiling reveals distinct correlations in atrophic gastritis associated with liver cirrhosis. | Front Cell Infect Microbiol | 2026 | 42698600 | PubTator, text mining | PubMed |
| Comparative efficacy and safety of methoxy polyethylene glycol-epoetin beta and roxadustat in the management of renal anemia in maintenance hemodialysis. | Front Pharmacol | 2026 | 42694056 | PubTator, text mining | PubMed |
| Engineering hematopoietic stem and progenitor cells to generate red blood cells as viral traps against HIV-1. | Mol Ther Adv | 2026 | 42662417 | PubTator, text mining | PubMed |
| Erythropoiesis-Targeted Doping in Sports: From Improved Oxygen Transport to Cardiovascular Risk. | Pathophysiology | 2026 | 42647239 | PubTator, text mining | PubMed |
| Joined Signatures of Erythropoietin and Interleukin-6 Signaling by Synthetic Heterodimeric gp130:Epo Receptor Complexes. | ACS Synth Biol | 2026 | 42632025 | PubTator, text mining | PubMed |
| Complex Genomic Alterations in TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia Involving EPOR/JAK2 Amplification, ERG Copy Gains, and TCF3 Deletion. | Genes Chromosomes Cancer | 2026 | 42568049 | PubTator, text mining | PubMed |
| Efficacy and Cardiovascular Safety of Pegmolesatide in Patients with Anemia of Chronic Kidney Disease: Post hoc Analysis of Two Phase 3 Randomized Trials. | Kidney Dis (Basel) | 2026 | 42553958 | PubTator, text mining | PubMed |
| EPOR Expression Is Independently Associated With Survival in Clear Cell Renal Cell Carcinoma. | Anticancer Res | 2026 | 42527057 | PubTator, text mining | PubMed |
| Plasma Proteins and Genes Associated with Protein and Risks for Diabetic Foot Diseases Identified Using Multi- Ornics and Mendelian Randomization Analysis. | Curr Med Chem | 2026 | 42509680 | PubTator, text mining | PubMed |
| Activating somatic EPOR mutation in primary erythrocytosis. | Pathology | 2026 | 42469066 | PubTator, text mining | PubMed |
Retraction notice to "Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway" [Exp. Cell Res. 361 (2017) 342-352]. | Exp Cell Res | 2026 | 42409713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2057/papers